LAMOTRIGINE ER 250 MG TABLET

lamotrigine extended release
$1.2926per EA

Strength

250 mg/1

Manufacturer

Endo USA Inc.

NDC

49884060411

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LAMOTRIGINE

Approval Type

Generic (ANDA)

FDA Application

ANDA201791

On Market Since

1/18/2013

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price History

1W

0.0%

1M

+5.0%

3M

+5.9%

6M

+16.3%

1Y

-33.4%

3Y

-66.9%

5Y

-77.1%

All

-90.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.